Search research articles
Contact Us
Filters
Showing results (221-230 of 304) with videos related to
Page
of 31
Sort By:
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 4, 2025
A Novel α-Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2025
A novel alpha-synuclein K58N missense variant in a patient with Parkinson's disease
Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
Journal of Parkinson'S Disease
|
October 3, 2025
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies
Ilham Y Abdi, Indulekha P Sudhakaran, Simona S Ghanem, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
European Journal of Human Genetics : EJHG
|
January 22, 2015
Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease
Eva C Schulte, Akio Fukumori, Brit Mollenhauer, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
NPJ Parkinson'S Disease
|
August 1, 2025
Large-scale copy number variant analysis in genes linked to Parkinson´s disease
Zied Landoulsi, Katja Lohmann, Eva-Juliane Vollstedt, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 304) with videos related to
Sort By:
Page
of 31
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 4, 2025
A Novel α-Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2025
A novel alpha-synuclein K58N missense variant in a patient with Parkinson's disease
Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 25, 2018
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni, Andrew Siderowf, Shirley Lasch, et al.
Journal of Parkinson'S Disease
|
October 3, 2025
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies
Ilham Y Abdi, Indulekha P Sudhakaran, Simona S Ghanem, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
European Journal of Human Genetics : EJHG
|
January 22, 2015
Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease
Eva C Schulte, Akio Fukumori, Brit Mollenhauer, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
NPJ Parkinson'S Disease
|
August 1, 2025
Large-scale copy number variant analysis in genes linked to Parkinson´s disease
Zied Landoulsi, Katja Lohmann, Eva-Juliane Vollstedt, et al.
Page
of 31